COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,635 Articles (22,913 medRxiv, 8,722 bioRxiv)

Most recent first Previous |  Page 512: Articles 5111-5120  | Next

SARS-CoV-2 post-vaccine surveillance studies in Australian children and adults with cancer: SerOzNET Statistical Analysis Plan
Body, A. L., Martin, C., Busija, L., Lal, L., Ahern, E. S., MacIntyre, R. C., Segelov, E.
10.1101/2023.02.26.23286261 — Posted: 2023-03-01
Coarse-Grained Molecular Simulations and Ensemble-Based Mutational Profiling of Protein Stability in the Different Functional Forms of the SARS-CoV-2 Spike Trimers : Balancing Stability and Adaptability in BA.1, BA.2 and BA.2.75 Variants
Verkhivker, G., Alshahrani, M., Gupta, G.
10.1101/2023.02.28.530489 — Posted: 2023-03-01
Bulk RNA-Sequencing of small airway cell cultures from IPF and post-COVID lung fibrosis patients illustrates disease signatures and differential responses to TGF-β1 treatment
Uhl, K., Paithankar, S., Leshchiner, D., Jager, T., Abdelgied, M., Tripp, K., Peraino, A., Kakazu, M., Lawson, C., Chesla, D., Prokop, J., Chen, B., Murphy, E., Girgis, R., Li, X.
10.1101/2023.03.01.530431 — Posted: 2023-03-01
Type I interferon signaling induces a delayed antiproliferative response in Calu-3 cells during SARS-CoV-2 infection
Cunha, J. B., Leix, K., Sherman, E. J., Mirabelli, C., Kennedy, A. A., Lauring, A. S., Tai, A. W., Wobus, C. E., Emmer, B. T.
10.1101/2023.02.28.530557 — Posted: 2023-03-01
COVID-19 adenoviral vector vaccination elicits a robust memory B cell response with the capacity to recognize Omicron BA.2 and BA.5 variants
Fryer, H. A., Hartley, G. E., Edwards, E. S. J., Varese, N., Boo, I., Bornheimer, S. J., Hogarth, P. M., Drummer, H. E., O'Hehir, R. E., van Zelm, M. C.
10.1101/2023.02.28.530547 — Posted: 2023-03-01
IgG4 serum levels are not elevated in cases of Post-COVID syndrome
Abel, J., Walter, A. J., Glueck, V., Magnus, C. L., Glueck, T., Schuster, P., Blaas, S., Montanari, I., Koller, M., Mohr, A., Hinterberger, T., Salzberger, B., Renner, K., Mack, M., Bals, R., Schmidt, T., Klemis, V., Sester, M., Kardashi, R., de With, K., Loew, T. H., Malfertheiner, M., Pfeifer, M., Gessner, A., Schmidt, B., Schmalenberger, D., Peterhoff, D.
10.1101/2023.03.01.530454 — Posted: 2023-03-01
SARS-CoV-2 ORF3c suppresses immune activation by inhibiting innate sensing
Mueller, M., Herrmann, A., Fujita, S., Kolberg, E. J., Kruth, C., Stange, A., Schneider, M., Ito, J., Ensser, A., The Genotype to Phenotype Japan (G2P-Japan) Consortium, , Sato, K., Sauter, D.
10.1101/2023.02.27.530232 — Posted: 2023-03-01
Elevated symptoms of depression and anxiety among family members and friends of critically ill COVID-19 patients - An observational study of five cohorts across four countries
Lovik, A., Gonzalez-Hijon, J., Hoffart, A., Fawns-Ritchie, C., Magnusdottir, I., Lu, L., Unnarsdottir, A. B., Kähler, A. K., Campbell, A., Hauksdottir, A., Chourpiliadis, C., McCartney, D. L., Thordardottir, E. B., Joyce, E. E., Frans, E. M., Jakobsdottir, J., Trogstad, L., Andreassen, O. A., Magnus, P., Johnson, S. U., Sullivan, P. F., Aspelund, T., Porteous, D. J., Ask, H., Ebrahimi, O. V., Valdimarsdottir, U. A., Fang, F.
10.1101/2023.02.28.23286559 — Posted: 2023-03-01
Mixed methods approach to examining the implementation experience of a phone-based health research survey investigating risk factors for SARS-CoV-2 infection in California
Fukui, N., Li, S. S., DeGuzman, J., Myers, J., Openshaw, J., Sharma, A., Watt, J., Lewnard, J., Jain, S., Andrejko, K., Pry, J. M.
10.1101/2023.02.27.23286454 — Posted: 2023-03-01
Combining models to generate a consensus effective reproduction number R for the COVID-19 epidemic status in England
Park, J., Bevan, L., Sanchez-Marroquin, A., Danelian, G., Bayley, T., Manley, H., Bowman, V., Maishman, T., Finnie, T., Charlett, A., Nowcasts Models Contribution Group, , Watkins, N. A., Hutchinson, J., Riley, S., Panovska-Griffiths, J.
10.1101/2023.02.27.23286501 — Posted: 2023-03-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).